Acticor Biotech

Acticor Biotech

France
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.
Founded date
01/01/2010
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$1M to $10M
# of funders
2
Founders
Antoine Reveau, Gilles Avenard
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
AGORANOV, Mirae Asset Capital, Anaxago, GO CAPITAL, Karista
# of funding runds
8
Last founding
$12.200.000
Total funded
$41.300.000

See more companies

See full list
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ICAgen

ICAgen

Estimated revenue
$10M to $50M
# of employees
11-50
Company type
For Profit
Rx Savings Solutions

Rx Savings Solutions

Estimated revenue
$1M to $10M
# of employees
251-500
Company type
For Profit
SEngine Precision Medicine

SEngine Precision Medicine

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
Symetrica

Symetrica

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
SmartScripts

SmartScripts

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
AngioChem

AngioChem

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
iotaMotion

iotaMotion

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.